Protecting author rights while maximizing global medical knowledge sharing.
Empowering Authors through Open Access
Journal of Hematology and Oncology Research operates under a permanent open access model, ensuring research is never locked behind paywalls.
We utilize Creative Commons Attribution 4.0 to balance accessibility with scholarly integrity.
In hematology and oncology, rapid dissemination can save lives. Traditional models often demand authors relinquish copyright, limiting sharing. At Journal of Hematology and Oncology Research, authors remain masters of their intellectual property. Our framework satisfies funder mandates while providing maximum reach.
All JHOR articles are published under the Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing reuse with proper credit.
Under this license, others are free to:
Share
Copy and redistribute the material in any medium or format.
Adapt
Remix and build upon the material for any purpose.
- Full ownership of the manuscript and published version.
- Right to use the article in future scholarly works and books.
- Immediate self-archiving in institutional repositories.
- Sharing on academic social networks and sites.
- Use of material for educational purposes.
Reuse requires proper attribution. A citation must include:
- Full author names and affiliations.
- Article title and Year of Publication.
- Journal name: Journal of Hematology and Oncology Research.
- DOI and a link to the CC BY 4.0 license.
The license applies to content created by authors. For third-party assets, you must:
- Obtain written permission from the copyright holder.
- Provide clear attribution in the caption.
- Ensure all material is legally cleared before submission.
Ready to Publish Open Access?
Advancing medicine through transparency. Last updated: January 2026.
Public Access and Funder Compliance
Some authors are required by their funders to make their research publicly available. Under the 2024 NIH Public Access Policy, Author Accepted Manuscripts accepted for publication on or after July 1, 2025, must be submitted to PubMed Central upon acceptance and made publicly available without embargo on the official date of publication.
What JHOR provides: JHOR publishes the Version of Record under the Creative Commons Attribution 4.0 International licence. The journal also permits authors to deposit their Author Accepted Manuscript in funder-designated repositories. Upon acceptance, we confirm the accepted manuscript version and record the funder and grant information supplied by the authors.
Author responsibility: JHOR does not currently deposit manuscripts in PubMed Central on behalf of authors. Authors are responsible for determining which funder requirements apply, initiating the appropriate repository submission and completing any required NIHMS approval steps.
Eligibility and successful processing through PubMed Central or NIHMS are determined according to the relevant funder and NIH/NLM requirements.
Important: The deposit of an individual article in PubMed Central may result in that article appearing in PubMed. It does not mean that JHOR is indexed in MEDLINE, included in the PMC Journal List or that all JHOR articles are available through PubMed. The journal's current coverage is listed on the Indexing page.
Editor in chief
